Mostrando 3 resultados de: 3
Filtros aplicados
Subtipo de publicación
Article(3)
Erectile function in men with type 2 diabetes treated with dulaglutide: an exploratory analysis of the REWIND placebo-controlled randomised trial
ArticleAbstract: Background: Diabetes is a major risk factor for erectile dysfunction, however, the effect of GLP-1 rPalabras claves:Autores:Bajaj H.S., Basile J.N., Colhoun H.M., Conget I., Cushman W.C., Dagenais G.R., Franek E., Gerstein H.C., Hanefeld M., Keltai M., Lakshmanan M., Lanas F.T., Leiter L.A., PATRICIO LOPEZ -JARAMILLO, Pirags V., Pogosova N., Probstfield J.L., Rao-Melacini P., Raubenheimer P.J., Rydén L.E., Shaw J.E., Sheu W.H.H., Xavier D.Fuentes:googlescopusEffects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: A pooled analysis of 96 population-based studies with 331 288 participants
ArticleAbstract: Background: Diabetes has been defined on the basis of different biomarkers, including fasting plasmaPalabras claves:Autores:Abu-Rmeileh N.M.E., Acosta-Cazares B., Aekplakorn W., Ahmadvand A., Alberto Barceló , Ali M.K., Alkerwi A., Amouyel P., Anderssen S.A., Angélica María Ochoa Aviles, Angélica Ochoa Avilés, Anjana R.M., Aounallah-Skhiri H., Aris T., Arlappa N., Arveiler D., Assah F.K., Avdicová M., Balakrishna N., Bandosz P., Barbagallo C.M., Batieha A.M., Baur L.A., Bentham J., Bernabe-Ortiz A., Bhargava S.K., Bi Y., Bixby H., Bjerregaard P., Björkelund C., Blake M., Blokstra A., Bo Andersen L., Bo S., Boehm B.O., Boissonnet C.P., Bovet P., Brajkovich I., Breckenkamp J., Brewster L.M., Brian G.R., Bruno G., Bugge A., Can G., Cåndido A.P.C., Capuano V., Carvalho M.J., Casanueva F.F., Caserta C.A., Castetbon K., Chamukuttan S., Chaturvedi N., Chen C.J., Chen F., Chen S., Cheng C.Y., Chetrit A., Chiou S.T., Cho Y., Chudek J., Cifkova R., Claessens F., Concin H., Cooper C., Cooper R., Costanzo S., Cottel D., Cowan M.J., Cowell C., Crujeiras A.B., D'Arrigo G., Dallongeville J., Danaei G., Dankner R.S., Dauchet L., de Gaetano G., De Henauw S., De León A.C., Deepa M., Dehghan A., Dhana K., Di Castelnuovo A.F., Di Cesare M., Dolores S. Andrade, Ezzati M., Fahimi S., Hajifathalian K., Kadir K.A., Khang Y.H., Lin J.K., Lo W.C., Lu Y., Magliano D., Miranda J.J., Nsour M.A., Reis-Santos B., Riley L.M., Romdhane H.B., Salinas C.A.A., Shaw J.E., Stevens G.A., Susana Andrade, Zhou B.Fuentes:rraaescopusThe effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial
ArticleAbstract: Background: Cardiovascular outcome trials have suggested that glucagon-like peptide 1 (GLP-1) receptPalabras claves:Autores:Atisso C.M., Avezum A.J., Basile J.N., Botros F.T., Colhoun H.M., Conget I., Cushman W.C., DIaz R., Dyal L., Gerstein H.C., Hall S., Hâncu N., Hanefeld M., Hart R.G., Jansky P., Keltai M., Lakshmanan M., Lanas F.T., Leiter L.A., Munoz E.G.C., PATRICIO LOPEZ -JARAMILLO, Pogosova N., Probstfield J.L., Raubenheimer P.J., Riddle M.C., Rydén L.E., Shaw J.E., Sheu W.H.H., Temelkova-Kurktschiev T.Fuentes:googlescopus